标靶定序市场－全球产业规模、份额、趋势、竞争格局、机会及预测，依产品类型、标靶富集方法、标靶捕获类型、应用、最终用户、地区及竞争格局划分，2020-2030年预测

2024年全球标靶定序市场规模为39亿美元，预计2030年将以11.10%的复合年增长率成长至73.3亿美元。全球标靶定序市场的核心是新一代定序技术，该技术能够精准地靶向和分析特定的基因组区域，例如特定基因或外显子，而非对整个基因组进行定序。这种聚焦式方法能够对选定区域提供高深度覆盖和高精度分析，从而高效且经济地识别对各种应用至关重要的遗传变异。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球标靶定序市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型（试剂盒/检测板及检测方法、仪器、其他）
  • 按标靶捕获类型（标靶DNA定序、标靶RNA定序、其他）
  • 透过标靶富集方法（扩增子定序、杂交捕获等）
  • 按最终用户划分（学术和研究机构、製药和生物技术公司、诊断和临床实验室、其他）
  • 依应用领域（肿瘤学、传染病学、心血管疾病、生殖健康、罕见疾病、神经系统疾病、遗传性疾病、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美标靶定序市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲标靶定序市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区标靶定序市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲标靶定序市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美标靶定序市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球标靶定序市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• MGI Tech Co., Ltd
• GENEWIZ Inc
• Agilent Technologies, Inc.
• Daicel Arbor Biosciences
• Danaher Corporation
• Illumina, Inc.
• LGC Biosearch Technologies
• Pacific Biosciences of California Inc
• CD Genomics
• F. Hoffmann-La Roche Ltd

第十六章：策略建议

第17章调查会社について・免责事项

The Global Targeted Sequencing Market, valued at USD 3.9 Billion in 2024, is projected to experience a CAGR of 11.10% to reach USD 7.33 Billion by 2030. The Global Targeted Sequencing Market centers on a next-generation sequencing technique that precisely targets and analyzes specific genomic regions, such as particular genes or exons, rather than sequencing the entire genome. This focused approach provides high-depth coverage and accuracy for selected areas, enabling efficient and cost-effective identification of genetic variants critical for various applications.

Key Market Drivers

The increasing global burden of genetic disorders and cancer represents a primary driving force behind the expansion of the Global Targeted Sequencing Market. The critical need for precise diagnostic tools and methods for disease characterization fuels the demand for targeted sequencing, which offers highly accurate and in-depth analysis of specific genomic regions relevant to these conditions. This technology enables earlier detection, guides personalized treatment strategies, and facilitates monitoring for recurrence or treatment response in oncology and rare disease settings. According to the World Health Organization, in February 2024, global cancer estimates for 2022 revealed approximately 20 million new cancer cases and 9.7 million deaths, highlighting the pervasive nature of this disease and the continuous requirement for advanced diagnostic solutions. Furthermore, targeted sequencing is instrumental in identifying the underlying genetic causes of rare diseases, which collectively affect millions worldwide.

Key Market Challenges

A significant challenge impeding the growth of the Global Targeted Sequencing Market is the absence of standardized guidelines and a unified consensus regarding the multitude of next-generation sequencing platforms and techniques. This fragmented landscape directly complicates widespread clinical adoption and the crucial processes of securing reimbursement for these advanced diagnostic tests. The lack of uniform standards creates ambiguity in test validation, interpretation, and reporting across different laboratories and healthcare providers.

This absence of standardization contributes to inconsistent payer policies, as each insurer may establish varying evidentiary requirements for assessing clinical utility, leading to unpredictable coverage and payment decisions. For instance, according to the College of American Pathologists, a 2.5% reduction in payment for pathology services, which includes molecular diagnostics, is anticipated starting January 2025, reflecting ongoing pressures on reimbursement and the complexities in valuing these intricate tests. Such financial uncertainty directly deters broader integration of targeted sequencing into routine clinical practice, limiting patient access to these critical diagnostic tools and consequently hindering overall market expansion.

Key Market Trends

Artificial intelligence and machine learning integration is profoundly transforming genomic data interpretation within targeted sequencing. These advanced computational methods are essential for efficiently analyzing the vast and complex datasets generated, enabling the rapid identification of subtle genetic variants and their clinical implications. This capability significantly enhances diagnostic precision and facilitates the development of personalized therapeutic approaches. Reflecting this growing importance, according to Roche, in April 2025, the company committed $50 billion over five years to its US pharmaceutical and diagnostics operations, including the establishment of a new research and development center focused on artificial intelligence research. This strategic investment highlights the industry's reliance on AI to convert genomic information into actionable clinical intelligence.

Key Market Players

• MGI Tech Co., Ltd
• GENEWIZ Inc
• Agilent Technologies, Inc.
• Daicel Arbor Biosciences
• Danaher Corporation
• Illumina, Inc.
• LGC Biosearch Technologies
• Pacific Biosciences of California Inc
• CD Genomics
• F. Hoffmann-La Roche Ltd

Report Scope:

In this report, the Global Targeted Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Targeted Sequencing Market, By Product Type:

• Kits/Panels and Assays
• Instruments
• Other

Targeted Sequencing Market, By Target Capture Type:

• Targeted DNA Sequencing
• Targeted RNA Sequencing
• Others

Targeted Sequencing Market, By Target Enrichment Method:

• Amplicon Sequencing
• Hybridization Capture
• Others

Targeted Sequencing Market, By End Users:

• Academic and Research Institution
• Pharmaceutical and Biotech Companies
• Diagnostic & Clinical Laboratories
• Other

Targeted Sequencing Market, By Application:

• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Reproductive Health
• Rare Diseases
• Neurological Disorders
• Hereditary Diseases
• Others

Targeted Sequencing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Targeted Sequencing Market.

Available Customizations:

Global Targeted Sequencing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Targeted Sequencing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Kits/Panels and Assays, Instruments, Other)
  • 5.2.2. By Target Capture Type (Targeted DNA Sequencing, Targeted RNA Sequencing, Others)
  • 5.2.3. By Target Enrichment Method (Amplicon Sequencing, Hybridization Capture, Others)
  • 5.2.4. By End Users (Academic and Research Institution, Pharmaceutical and Biotech Companies, Diagnostic & Clinical Laboratories, Other)
  • 5.2.5. By Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Reproductive Health, Rare Diseases, Neurological Disorders, Hereditary Diseases, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Targeted Sequencing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Target Capture Type
  • 6.2.3. By Target Enrichment Method
  • 6.2.4. By End Users
  • 6.2.5. By Application
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Targeted Sequencing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Target Capture Type
      • 6.3.1.2.3. By Target Enrichment Method
      • 6.3.1.2.4. By End Users
      • 6.3.1.2.5. By Application
  • 6.3.2. Canada Targeted Sequencing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Target Capture Type
      • 6.3.2.2.3. By Target Enrichment Method
      • 6.3.2.2.4. By End Users
      • 6.3.2.2.5. By Application
  • 6.3.3. Mexico Targeted Sequencing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Target Capture Type
      • 6.3.3.2.3. By Target Enrichment Method
      • 6.3.3.2.4. By End Users
      • 6.3.3.2.5. By Application

7. Europe Targeted Sequencing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Target Capture Type
  • 7.2.3. By Target Enrichment Method
  • 7.2.4. By End Users
  • 7.2.5. By Application
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Targeted Sequencing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Target Capture Type
      • 7.3.1.2.3. By Target Enrichment Method
      • 7.3.1.2.4. By End Users
      • 7.3.1.2.5. By Application
  • 7.3.2. France Targeted Sequencing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Target Capture Type
      • 7.3.2.2.3. By Target Enrichment Method
      • 7.3.2.2.4. By End Users
      • 7.3.2.2.5. By Application
  • 7.3.3. United Kingdom Targeted Sequencing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Target Capture Type
      • 7.3.3.2.3. By Target Enrichment Method
      • 7.3.3.2.4. By End Users
      • 7.3.3.2.5. By Application
  • 7.3.4. Italy Targeted Sequencing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Target Capture Type
      • 7.3.4.2.3. By Target Enrichment Method
      • 7.3.4.2.4. By End Users
      • 7.3.4.2.5. By Application
  • 7.3.5. Spain Targeted Sequencing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Target Capture Type
      • 7.3.5.2.3. By Target Enrichment Method
      • 7.3.5.2.4. By End Users
      • 7.3.5.2.5. By Application

8. Asia Pacific Targeted Sequencing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Target Capture Type
  • 8.2.3. By Target Enrichment Method
  • 8.2.4. By End Users
  • 8.2.5. By Application
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Targeted Sequencing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Target Capture Type
      • 8.3.1.2.3. By Target Enrichment Method
      • 8.3.1.2.4. By End Users
      • 8.3.1.2.5. By Application
  • 8.3.2. India Targeted Sequencing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Target Capture Type
      • 8.3.2.2.3. By Target Enrichment Method
      • 8.3.2.2.4. By End Users
      • 8.3.2.2.5. By Application
  • 8.3.3. Japan Targeted Sequencing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Target Capture Type
      • 8.3.3.2.3. By Target Enrichment Method
      • 8.3.3.2.4. By End Users
      • 8.3.3.2.5. By Application
  • 8.3.4. South Korea Targeted Sequencing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Target Capture Type
      • 8.3.4.2.3. By Target Enrichment Method
      • 8.3.4.2.4. By End Users
      • 8.3.4.2.5. By Application
  • 8.3.5. Australia Targeted Sequencing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Target Capture Type
      • 8.3.5.2.3. By Target Enrichment Method
      • 8.3.5.2.4. By End Users
      • 8.3.5.2.5. By Application

9. Middle East & Africa Targeted Sequencing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Target Capture Type
  • 9.2.3. By Target Enrichment Method
  • 9.2.4. By End Users
  • 9.2.5. By Application
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Targeted Sequencing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Target Capture Type
      • 9.3.1.2.3. By Target Enrichment Method
      • 9.3.1.2.4. By End Users
      • 9.3.1.2.5. By Application
  • 9.3.2. UAE Targeted Sequencing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Target Capture Type
      • 9.3.2.2.3. By Target Enrichment Method
      • 9.3.2.2.4. By End Users
      • 9.3.2.2.5. By Application
  • 9.3.3. South Africa Targeted Sequencing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Target Capture Type
      • 9.3.3.2.3. By Target Enrichment Method
      • 9.3.3.2.4. By End Users
      • 9.3.3.2.5. By Application

10. South America Targeted Sequencing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Target Capture Type
  • 10.2.3. By Target Enrichment Method
  • 10.2.4. By End Users
  • 10.2.5. By Application
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Targeted Sequencing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Target Capture Type
      • 10.3.1.2.3. By Target Enrichment Method
      • 10.3.1.2.4. By End Users
      • 10.3.1.2.5. By Application
  • 10.3.2. Colombia Targeted Sequencing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Target Capture Type
      • 10.3.2.2.3. By Target Enrichment Method
      • 10.3.2.2.4. By End Users
      • 10.3.2.2.5. By Application
  • 10.3.3. Argentina Targeted Sequencing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Target Capture Type
      • 10.3.3.2.3. By Target Enrichment Method
      • 10.3.3.2.4. By End Users
      • 10.3.3.2.5. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Targeted Sequencing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. MGI Tech Co., Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. GENEWIZ Inc
• 15.3. Agilent Technologies, Inc.
• 15.4. Daicel Arbor Biosciences
• 15.5. Danaher Corporation
• 15.6. Illumina, Inc.
• 15.7. LGC Biosearch Technologies
• 15.8. Pacific Biosciences of California Inc
• 15.9. CD Genomics
• 15.10. F. Hoffmann-La Roche Ltd

16. Strategic Recommendations

17. About Us & Disclaimer